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http://dx.doi.org/10.1016/j.jacl.2016.0BACKGROUND: Both triglyceride-to-high density lipoprotein cholesterol (TG/HDL-C) and cardio-
respiratory fitness (CRF) impart risk for all-cause morbidity and mortality independently of conven-
tional risk factors.
OBJECTIVE: Todetermine prevalence and/or incidence of highTG/HDL-C ratio inmenwith lowCRF.
METHODS: Clinical characteristics and CRF were used to determine prevalence of a TG/HDL-C ratio
$ 3.5 (high ratio) in 13,954 men of the Cooper Center Longitudinal Study. High-ratio conversion was
determined in 10,424 men with normal baseline TG/HDL-C ratio. Hazard ratio (HR) of incident high
TG/HDL-C was adjusted for age and waist girth.
RESULTS: Menwith lowCRF had the highest prevalence of a high TG/HDL-C ratio. In the population
with normal TG/HDL-C, age-adjustedHR of incident high TG/HDL-C ratiowas 2.77 times higher inmen
with lowest CRF than in thosewith highest CRF. Incidence of conversion of normal to high ratiowas 5.5%
per year in low CRF population, compared with 1.7% in high CRF subjects. Incidence HR was indepen-
dent of waist girth.Men who converted from normal to high TG/HDL-C ratio during the follow-up period
had increased number of metabolic risk factors and a higher prevalence of metabolic syndrome.Menwho
did not convert to a high TG/HDL-C ratio retained a low prevalence of metabolic syndrome risk factors.
CONCLUSION: Ahigh TG/HDL-C ratio is common inmenwith lowCRF.Metabolic syndrome also is
common among those with a high ratio.
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9.008Introduction
Moderately elevated levels of plasma triglyceride
impart risk for cardiovascular disease beyond the risk
expected from high low density lipoprotein (LDL) or low
high density lipoprotein (HDL) cholesterol (C) levels.1,2is is an open access article under the CC BY-NC-ND license (http://
Vega et al High TG/HDL C ratio in low cardiorespiratory fitness 1415Since a low HDL-C is also predictive, a high ratio of
triglyceride-to-high density lipoprotein cholesterol (TG/
HDL-C) should be doubly so. Indeed, a high ratio is pre-
dictive for all-cause and cardiovascular disease mortality
in men, in women with suspected myocardial ischemia,
and in patients with type II diabetes mellitus.3–5 A high
ratio further is highly associated with incidence of type
II diabetes mellitus.3 In addition, a high triglyceride
and/or low HDL-C is a common lipoprotein phenotype
secondary to insulin resistance, and some studies report
that a high TG/HDL-C ratio predicts insulin resistance,6
LDL particle number, presence of small, dense LDL,
and the risk of heart disease.7–9 Thus, it appears that the
TG/HDL-C ratio may be clinically useful as an indicator
of risk.
Another risk for premature all-cause and cardiovascu-
lar disease mortality is low cardiorespiratory fitness
(CRF) level.10–12 CRF is an age- and sex-specific measure
of cardiovascular function during maximal exercise per-
formance on a treadmill. Recently, the relation of CRF
to metabolic risk was examined in the study population
of the Cooper Center Longitudinal Study (CCLS). It
was noted that prevalence of metabolic risk factors for
cardiovascular disease accounted for a portion of the
increased cardiovascular mortality in low-CRF subjects.13
Farrell et al14 reported an inverse association of CRF to
metabolic syndrome in women. In addition, other studies
suggest that high CRF imparts protection from mortality
risk due to insulin resistant conditions such as obesity.15
Because a high ratio of TG/HDL-C is predictive of risk
for all-cause and cardiovascular mortality and of insulin
resistance, we examined the incidence of the high ratio
in relation to CRF.Methods
For this report, a secondary data analysis was conduct-
ed of subjects who presented to the Cooper Clinic at
Dallas, Texas, for a preventive medical visit during 1979
to 2010 and who were enrolled and consented to
participate in CCLS. This study is approved by the
Institutional Review Board for Investigation in Humans
at The Cooper Institute. The CCLS is an ongoing
prospective cohort study primarily designed to investigate
the effect of CRF on cardiometabolic disease and death.
Patients enrolled in the CCLS are mostly non-Hispanic
white, about 80% are college graduates, and the subjects
are from middle to upper socioeconomic strata. There
were a total of 24,074 subjects available for analyses.
Women (n 5 4623), young (,20 years) or older
(.80 years) individuals, subjects with diabetes
(glucose $ 126 mg/dL or had history of diabetes at
baseline), and individuals consuming more than 14
alcoholic drinks/week at baseline or/and current smokers
at baseline (n 5 1944) were excluded. In addition,
subjects with a follow-up visit date that was the same asbaseline (n 5 25) were excluded. Thus, a total of 13, 954
men met inclusion criteria, of these, 10,424 analytic
samples had a normal TG/HDL-C ratio (,3.5) at baseline
and qualified for analysis of the incidence of a high ratio
($3.5).
As described previously,16 the clinical examination
followed a 12-hour fast and included a detailed medical
history, physical examination, health habits question-
naire, anthropometric measurements, resting and exercise
electrocardiograms, blood chemistry analyses, blood
pressure measurement, and a standardized maximal exer-
cise test.
Measures
After a 12-hour fast, serum samples were analyzed for
triglyceride, total cholesterol, HDL-C, and estimation of
non-HDL-C (total cholesterol minus HDL-C). The assays
used were automated in accord with standard operating
procedures.16 A cut point of 3.5 was chosen for the ratio of
TG/HDL-C as described previously.3,8
Body composition measurements were taken at the
clinical visit according to a manual of operations by trained
technicians and have been described previously.16 Briefly,
body mass index (kg/m2) was computed from measured
height and weight. Waist girth (cm) was measured to the
nearest 0.1 cm at the level with the umbilicus after a normal
exhalation.
Resting blood pressure was auscultated as the first and
fifth Korotkoff sounds according to a standard sphygmo-
manometer protocol.
Metabolic syndrome
Metabolic syndrome was defined using the Adult
Treatment Panel III criteria.17 Briefly, classification into
metabolic syndrome required 3 of the following criteria:
waist girth $ 102 cm, TG $ 150 mg/dL, HDL-C ,
40 mg/dL, and systolic blood pressure $ 130 mm Hg or
diastolic blood pressure $ 80 mm Hg. Blood glucose cut
point was defined for this study based on our previous
assessment of high-risk glucose cut point for type II dia-
betes mellitus.16 Accordingly, high glucose was defined in
the range of 110 mg/dL to 125 mg/dL. Prevalence of
each risk factor for metabolic syndrome also was evaluated.
Physical activity
In the Health Habits Questionnaire, subjects were asked
to provide information about their usual patterns of regular
exercise, which was used to create physical activity (PA)
categories (0 5 no reported PA; 1 5 participated in sports
or exercise activities other than walking or running;
2 5 walked or ran less than 10 miles/wk; 3 5 walked or
ran 11–19 miles per week; 4 5 walked or ran 20 or more
miles/wk).18 In this study, physical activity indices (PAIs)
are summarized.
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Briefly, CRF was evaluated with a modified-Balke
protocol.19 In the first minute, the grade is set at 0%, fol-
lowed by 2% in the second minute and increased by 1%
every minute thereafter. The test is completed when the
participant reports exhaustion, experiences marked increase
in blood pressure, or the attending physician discontinues
the test for medical reasons. With this protocol, the exercise
time correlates highly with maximal oxygen uptake in men
(r 5 0.92) and allows estimation of fitness in metabolic
equivalents (METs) (1 MET 5 3.5 mL/kg per minute of
oxygen consumption).19
Low CRF was defined using the criteria and normative
data on treadmill performance established by Willis
et al.20 Briefly, subjects were classified into CRF cate-
gories according to treadmill time. The threshold tread-
mill times used for classification into each of the CRF
categories are shown in Supplemental Table 1. The lowest
CRF category (C1) corresponds to the 1st–20th percentile
of the entire CCLS population–specific for age and
gender, whereas the highest CRF category (C5) is above
the 80th percentile for the same population. Historically,
subjects in C1 have experienced the highest rates of
morbidity and mortality. The C2 and C3 categories are
moderately fit by definition and the highest fit is defined
as categories C4 and C5. In the present study, the number
of subjects per category represents men who met inclu-
sion/exclusion criteria for the study in addition to the
fitness classification derived for the entire CCLS cohort.
Therefore, the number of men per category varies in the
present study.Table 1 Characteristics of all men at baseline
CRF category* C1 C2
Number of men 1018 2043
Age (y) 44 (8)† 45 (9)
Physical activity index 0.9 (0.9)† 1.1 (0.9)
Cardiorespiratory fitness (METs) 8.7 (1.0)† 10.1 (1.0)
Waist girth (cm) 104.2 (12.2)† 97.8 (9.6)
Hip girth (cm) 111.0 (7.6)† 105.9 (7.6)
BMI (kg/m2) 30.8 (5.2)† 28 (3.7)
Triglycerides (mg/dL) 174 (111)† 152 (99)
HDL cholesterol (mg/dL) 41 (10)† 43 (10)
Fasting blood glucose (mg/dL) 99 (10)† 98 (9)
non-HDL cholesterol (mg/dL) 168 (40)† 163 (39)
Systolic blood pressure (mm Hg) 124 (13)† 121 (13)
Diastolic blood pressure (mm Hg) 84.4 (9.9)† 82.6 (0.5)
Hypertension (%) 24.5† 17
Metabolic syndrome (%) 52.4† 35.6
CRF, cardiorespiratory fitness; METs, 1 metabolic equivalent 5 3.5 mL O2 u
*Categories of CRF are defined by treadmill time thresholds shown in Supp
†All trends are significant; P , .001.Analysis design
Two analyses were conducted with the data in this
study. First, data from 13,954 men that met inclusion/
exclusion criteria were used to determine mean TG/HDL
C ratio as a function of CRF category from low CRF (C1)
to high CRF (C5). Prevalence of a high ratio across
cardiorespiratory category also was measured in this group
of men. Second, data from 10,424 men who had a TG/
HDL-C ratio , 3.5 at baseline and met all other inclusion/
exclusion criteria was used to determine the incidence and
hazard ratio (HR) of a high TG/HDL-C across the 5 CRF
categories.
Statistical analysis
Descriptive characteristics of the study sample were
presented for each CRF category for the entire male
population and for the subgroups that converted from a
normal TG/HDL-C ratio (,3.5) to a high ratio ($3.5) or
did not convert. Trends across ordered CRF categories at
baseline were tested using the nonparametric Jonckheere-
Terpstra method. Crude incidence of TG/HDL-C$ 3.5 was
estimated within CRF categories as the number of TG/
HDL-C $ 3.5 events divided by the total follow-up in
years. Adjusted HRs for incident TG/HDL-C $ 3.5 were
estimated by fitting a Weibull distributed–accelerated fail-
ure time model to the observed failure times, which were
interval censored between examination dates. Comparisons
between baseline and follow-up values of continuous
variables were made by applying nonparametric sign tests
to the paired differences. Analyses were performed usingC3 C4 C5 All
2814 3920 4159 13,954
46 (9) 46 (9) 46 (10) 45 (9)
1.4 (1.0) 1.8 (1.0) 2.4 (1.1) 1.7 (1.1)
11.1 (1.0) 12.4 (1.0) 14.6 (1.8) 12.2 (2.3)
94.5 (8.5) 91.3 (7.7) 86.8 (7.0) 92.5 (9.7)
103.8 (7.3) 101.6 (5.9) 98.5 (5.5) 102.6 (7.7)
26.9 (3.2) 25.9 (2.6) 24.5 (2.2) 26.4 (3.5)
139 (118) 118 (74) 94 (55) 124 (0.4)
45 (11) 47 (12) 52 (12) 47 (12)
97 (9) 97 (8) 96 (8) 97 (9)
160 (40) 153 (37) 144 (36) 154 (39)
121 (12) 121 (13) 120 (13) 121 (13)
81.6 (0.3) 80.2 (0.2) 79 (8.8) 80.8 (99.3)
13.2 11.9 8.5 12.8
24.1 15.4 6.1 20.0
ptake/kg body weight per minute.
lemental Table 1.
Figure 1 Mean TG/HDL-C ratios as a function of cardiorespiratory fitness (CRF) categories (low CRF [C1] to high CRF [C5]) at baseline
(A) for all men. Individuals with the lowest CRF had the highest ratios of TG/HDL-C. The prevalence of TG/HDL-C ratio $ 3.5 also was
highest in men with low CRF (C1) (B). aP , .001 by trend analysis.
Vega et al High TG/HDL C ratio in low cardiorespiratory fitness 1417SAS/STAT, version 9.4. All significance testing was 2 sided
with a P value of less than .05 considered statistically
significant.
Results
Prevalence of a high TG/HDL-C ratio as a
function of CRF
Men were grouped according to 5 CRF categories20
based on the treadmill time range per category described
in Supplemental Table 1. About 7% of the 13,954 men
had low CRF (C1), and w30% had high CRF (C5;
Table 1). Men with the lowest CRF had central obesity
and elevated non-HDL-C; they had moderately elevated
plasma triglycerides and did not have impaired fasting
glucose. They also had the highest prevalence of hyperten-
sion and metabolic syndrome among the CRF subgroups.
The PAI also was the lowest among all CRF categories.
In contrast, men with the highest CRF (C5) did not haveFigure 2 Incidence of high TG/HDL-C ratio in men who had a
normal ratio at baseline and were followed up for 5.1 years on
average. The incidence of the high ratio was highest in men
with the lowest CRF (C1). aP , .001 by trend analysis.central obesity, they were normolipidemic, euglycemic,
and they had the lowest prevalence of hypertension and
metabolic syndrome (Table 1).
The mean ratio of TG/HDL-C decreased with increasing
CRF (Fig. 1A) and a similar inverse trend was observed for
the prevalence of the high ratio as a function of CRF
(Fig. 1B). Men with the lowest CRF had the highest TG/
HDL-C ratio and the highest prevalence of a high ratio.
Incidence of high TG/HDL-C ratio as a function
of CRF
In men with a normal TG/HDL-C ratio at baseline
(n 5 10,424), there was an inverse relationship between CRF
category and the incidence of a high TG/HDL-C ratio (Fig. 2).
The HR of a high TG/HDL-C ratio in men with a low
CRF (C1) or intermediate CRF (categories 2 through 4)
was examined using the highest CRF category (C5) as the








Hazard ratio (95 percentile confidence intervals)
C1 2.77 (2.28–3.35) 1.77 (1.42–2.20)
C2 2.11 (1.82–2.44) 1.63 (1.39–1.91)
C3 1.94 (1.70–2.21) 1.61 (1.41–1.85)
C4 1.47 (1.31–1.67) 1.33 (1.17–1.50)
C5 1.00 1.00
CRF, cardiorespiratory fitness.
*CRF is defined by treadmill time thresholds shown in Supplemental
Table 1.
Table 3 Characteristics of men who crossed the threshold TG/HDL-C ratio of 3.5 during an average 5.1-y follow-up
Number of men
CRF category*
C1 C2 C3 C4 C5
134 278 421 536 498
Mean (SD)
Age (y) Baseline 43.7 (7.8) 43.1 (9) 45.1 (8.6) 44.1 (9.1) 45.1 (9.9)
Follow-up 48.1 (8.0) 48.4 (8.8) 49.7 (8.7) 49.3 (9.1) 50.9 (9.2)
Physical activity index Baseline 0.9 (0.9) 1.2 (1.0) 1.4 (1.0) 1.8 (1.0) 2.4 (1.2)
Follow-up 1.1 (1.0) 1.2 (1.0) 1.4 (1.0) 1.6 (1.1) 1.9 (1.2)
Cardiorespiratory
fitness (METs)
Baseline 8.9 (0.9) 10.3 (0.9) 11.2 (0.9) 12.5 (1.0) 14.4 (1.7)
Follow-up 9.1 (1.5) 10.3 (1.4) 11.2 (1.5) 12.0 (1.6) 13.3 (2.1)
Waist girth (cm) Baseline 103.4 (11.7) 97 (9.2) 93.9 (8.5) 91.5 (7.1) 88.7 (6.6)
Follow-up 105.0 (12.3) 99.2 (9.8) 96.2 (8.5) 94.8 (7.8) 92.4 (7.9)
Hip girth (cm) Baseline 109.5 (9.2) 105.3 (7.7) 103.1 (6.0) 101.2 (5.2) 99.7 (5.1)
Follow-up 110.3 (10.4) 106.2 (8.5) 103.7 (7.0) 102.5 (6.2) 101.1 (5.9)
BMI (kg/m2) Baseline 30.3 (4.9) 27.8 (3.5) 26.6 (3.0) 25.9 (2.6) 25 (2.2)
Follow0-up 31.2 (5.2) 28.8 (3.8) 27.5 (3.5) 27.0 (3.0) 26.2 (2.8)
Blood glucose (mg/dL) Baseline 99 (9) 97 (8) 97 (8) 97 (8) 97 (8)
Follow-up 105 (28) 100 (11) 98 (9) 98 (11) 98 (9)
Triglycerides (mg/dL) Baseline 118 (26) 111 (30) 112 (29) 108 (28) 103 (30)
Follow-up 190 (61) 185 (55) 182 (53) 191 (79) 188 (70)
HDL cholesterol (mg/
dL)
Baseline 43 (7) 43 (7) 43 (7) 44 (8) 45 (8)
Follow-up 39 (7) 39 (7) 39 (7) 39 (7) 40 (7)
TG/HDL cholesterol
ratio
Baseline 2.8 (0.6) 2.6 (0.7) 2.6 (0.6) 2.5 (0.7) 2.4 (0.7)
Follow-up 5.0 (1.9) 4.8 (1.4) 4.8 (1.6) 5.0 (2.9) 4.8 (1.8)
Non-HDL cholesterol
(mg/dL)
Baseline 159 (37) 159 (34) 161 (35) 159 (35) 156 (36)
Follow-up 163 (36) 165 (38) 167 (35) 167 (34) 168 (36)
Systolic blood pressure
(Hg mm)
Baseline 123.1 (14.3) 120.2 (11.9) 119.8 (12.1) 119.1 (12.7) 119.3 (13.0)
Follow-up 122.6 (12.3) 121.8 (12.5) 121.7 (13.1) 121.7 (11.9) 121.8 (12.5)
Diastolic blood pres-
sure (Hg mm)
Baseline 83.2 (10.7) 81.5 (8.6) 81.1 (9.5) 79.8 (9.1) 79.1 (8.9)
Follow-up 82.3 (10.1) 83.2 (8.9) 82.0 (8.9) 81.5 (8.5) 81.2 (8.7)
SD, standard deviation.
Bold numbers represent follow-up values that are significantly different from baseline; P , .05; follow-up vs baseline ages differ by design.
*Categories of CRF are defined by treadmill time thresholds shown in Supplemental Table 1.
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Men with the lowest CRF had the highest HR for having a
high TG/HDL-C ratio (Table 2). The HR remained signifi-
cantly associated with a low CRF after adjustment for age
and waist girth.
Changes from baseline characteristics at the
follow-up visit
Fourteen percent of the 10,424 men with a normal TG/
HDL C ratio at baseline converted to a high ratio ($ 3.5),
during the follow-up period of analysis. These men also
increased their weight, plasma triglycerides and non-HDL-
C levels from baseline (Table 3). The HDL-C levels
decreased during follow-up. The ratio of TG/HDL-C also
was markedly increased, regardless of the CRF level. In
contrast, blood pressure and fasting blood glucose
increased modestly in this subgroup (Table 3). Some
changes were noted in CRF and PAI.
Men who did not cross the threshold TG/HDL-C ratio
(n 5 8558) had not changed markedly from the baselinecharacteristics (Table 4). There was no evidence of increased
prevalence of obesity and in addition, there was an improve-
ment in levels of HDL-C and non-HDL-C regardless of the
baseline CRF category. The ratio of TG/HDL-C decreased
modestly at each CRF category within this group. However,
blood pressure increased modestly in the higher CRF cate-
gories but not in the low CRF group (Table 4).
Prevalence of metabolic syndrome
The prevalence of metabolic syndrome was highest in
men with low CRF at baseline and at follow-up (Fig. 3). In
the subgroup of men that converted to a high TG/HDL-C
ratio, the prevalence was markedly increased at every
CRF category (Fig. 3A). Metabolic syndrome prevalence
increased not only in men with low CRF but also in men
with high CRF. In contrast, metabolic syndrome prevalence
in the group of men who did not convert to a high TG/HDL-
C ratio remained the same as in baseline. Still, the low CRF
group retained a high prevalence of metabolic syndrome
(Fig. 3B). Overall, metabolic syndrome was most prevalent




C1 C2 C3 C4 C5
374 928 1510 2502 3244
Mean (SD)
Age (y) Baseline 44 (8.8) 44.7 (9.5) 45.5 (9.3) 45.4 (9.4) 45.8 (9.5)
Follow-up 49.1 (9.5) 50.8 (10.2) 52 (10.2) 52.5 (10.4) 54 (11)
Physical activity index Baseline 0.9 (0.9) 1.1 (0.9) 1.4 (0.9) 1.8 (1.0) 2.4 (1.1)
Follow-up 1.2 (0.9) 1.4 (1.0) 1.4 (1.0) 1.6 (1.1) 2.0 (1.2)
Cardiorespiratory fitness (METs) Baseline 8.6 (1.0) 10.1 (1.0) 11.2 (1.1) 12.4 (1.0) 14.8 (1.8)
Follow-up 9.5 (1.8) 10.7 (1.7) 11.3 (1.8) 12.1 (1.8) 13.7 (2.4)
Waist girth (cm) Baseline 102.5 (12.4) 95.8 (9.5) 93.2 (8.5) 90.1 (7.6) 86 (6.8)
Follow-up 101.0 (12) 95.2 (9.9) 93.4 (9.0) 90.7 (8.1) 87.5 (7.5)
Hip girth (cm) Baseline 111.1 (10.4) 105.2 (7.6) 103.1 (6.8) 101.2 (6.0) 98.3 (5.5)
Follow-up 109.4 (10.3) 103.8 (7.8) 102.5 (7.7) 100.7 (6.2) 98.3 (5.8)
BMI (kg/m2) Baseline 30.4 (5.4) 27.4 (3.7) 26.4 (3.1) 25.6 (2.6) 24.3 (2.2)
Follow-up 30.2 (5.1) 27.4 (3.8) 26.7 (3.4) 25.9 (2.8) 24.9 (2.4)
Blood glucose (mg/dL) Baseline 97 (9) 97 (9) 97 (8.4) 96 (8) 96 (8)
Follow-up 97 (9) 98 (11) 97 (11) 96 (9) 96 (7)
Triglycerides (mg/dL) Baseline 99 (32) 95 (31) 91 (31) 87 (30) 79 (29)
Follow-up 91 (30) 91 (30) 90 (31) 87 (30) 80 (29)
HDL cholesterol (mg/dL) Baseline 47 (9) 49 (10) 50 (10) 52 (11) 54 (12)
Follow-up 50 (11) 52 (11) 54 (12) 55 (13) 58 (14)
TG/HDL cholesterol ratio Baseline 2.2 (0.8) 2.0 (0.7) 1.9 (0.7) 1.8 (0.7) 1.5 (0.7)
Follow-up 1.9 (0.7) 1.9 (0.7) 1.8 (0.7) 1.7 (0.7) 1.5 (0.7)
Non-HDL cholesterol (mg/dL) Baseline 151 (36) 150 (36) 149 (36) 144 (34) 139 (34)
Follow-up 138 (38) 136 (35) 137 (38) 134 (35) 128 (35)
Systolic blood pressure (mm Hg) Baseline 122.6 (13.4) 120.1 (12.3) 119.8 (12.1) 119.6 (12.8) 119.4 (12.7)
Follow-up 122.1 (13.2) 120.3 (12.6) 120.6 (13.2) 120.0 (13.0) 121 (13.4)
Diastolic blood pressure (mmHg) Baseline 84.0 (10.1) 81.6 (9.4) 80.7 (9.2) 79.6 (9.2) 78.8 (8.7)
Follow-up 82.3 (9.7) 80.5 (9.0) 80.3 (9.1) 79.3 (8.8) 79.1 (8.8)
Bold numbers represent follow-up values that are significantly different from baseline; P , .05; follow-up vs baseline ages differ by design.
*Categories of CRF are defined by treadmill time thresholds shown in Supplemental Table 1.
Vega et al High TG/HDL C ratio in low cardiorespiratory fitness 1419in subjects with low CRF than those with the high CRF
regardless of the TG/HDL-C ratio classification.
Discussion
The CCLS cohort has been followed since 1970 and it
has been consistently shown in this population that low
CRF imparts risk of mortality from all-cause and cardio-
vascular disease independently of other established risk
factors.10,11 This finding is not unique to the CCLS popula-
tion since a similar relationship has been reported in other
populations.11,21–23 The mechanisms underlying this rela-
tionship are still unknown. Here we show that a high ratio
of TG/HDL-C occurs more commonly in men with low
CRF. A high HR for TG/HDL-C was found in men with
low CRF and this was independent of age or waist girth.
These findings indicate that a high TG/HDL-C is strongly
associated with low CRF.
A high TG/HDL-C ratio has been reported to associate
with several metabolic derangements. Associated lipid
abnormalities include increased remnant lipoprotein parti-
cle cholesterol (RLP-C),24 elevated apolipoprotein B,25 andsmall LDL particles,26,27 reduced lipoprotein lipase,
increased hepatic lipase,28 and increased cholesteryl ester
transfer protein.29 Other metabolic associations include in-
sulin resistance,8,30–33 beta cell dysfunction,34 metabolic
syndrome,35 diabetes incidence,3 incident fatty liver,36
waist-to-hip ratio, and reduced hip circumference.35 A
high ratio is further associated with subclinical atheroscle-
rosis,37,38 major cardiovascular events,35,39 chronic kidney
disease,40 and total mortality.3
The association between a high TG/HDL-C ratio and low
CRF could be mediated in part by obesity. A high percentage
of persons with a low CRF are obese.41 In general, obesity is
accompanied by higher serum TG levels and lower HDL-C
concentrations. These effects appear to be due largely to
overloading the liver with lipid. Most of this overload is sec-
ondary to increased caloric intake. Excessive nutrient input
into the liver leads to overproduction of triglyceride-rich
lipoproteins, hence higher serum TG42 and increased
expression of hepatic lipase, and lower HDL-C.43
A low CRF in obese persons could be secondary to
abnormalities in muscle metabolism. Several studies show
that obesity is accompanied by decreased mitochondrial
Figure 3 Prevalence of metabolic syndrome among subjects with a high (A) and a normal (B) TG/HDL-C ratio by CRF category. At
baseline (black bars) the prevalence of metabolic syndrome is highest among subjects with the lowest CRF (C1) (A and B). At the
follow-up visit (white bars), those men who crossed over the threshold of the ratio have high prevalence of metabolic syndrome at every
CRF category. Still, the lowest CRF group had the highest ratio (A). In contrast, men who retained a normal TG/HDL-C ratio at follow-up
also retained the same prevalence of metabolic syndrome seen at baseline (B). aP , .001 by trend analysis.
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could be one mechanism of reduced CRF. How obesity
might cause decreased mitochondrial oxidative phosphory-
lation is not apparent. Some investigators contend that this
effect is mediated by insulin resistance.48,49 But whether in-
sulin resistance is the cause of mitochondrial dysfunction or
the result of it is uncertain. If fatty acid oxidation in skeletal
muscle is impaired in obese persons, excess lipid could be
diverted to liver to accentuate dyslipidemia.
Chronic physical inactivity apparently is another char-
acteristic of persons with a low CRF.50 PA is known to
reduce triglycerides and raise HDL-C.51 It promotes energy
expenditure in muscle and thereby lessens the load of any
excess caloric intake on the liver. Physical inactivity should
have the reverse effect and enhance nutrient load on the
liver, which in turn will raise serum triglycerides and
reduce HDL-C. PA is known to lessen insulin resistance
in skeletal muscle52 and to increase oxidative
phosphorylation.53
Some portion of the population is genetically prone to a
high TG/HDL-C ratio. The regulation of lipoprotein
metabolism is complex, and multiple genetic variants are
known to produce dyslipidemia. Among these are abnor-
malities in lipoprotein lipase and related lipases and defects
in the regulation of HDL metabolism whether these
abnormalities in any way impair CRF is unknown. It is
known however that strong genetic factors influence
CRF54,55; and a genetically low CRF may associate with
a high TG/HDL-C ratio.
This study adds to the list of important associations with
a high TG/HDL-C ratio for a male population of non-
Africans. Thus, in our view, this ratio could be a useful
marker for cardiovascular and metabolic risk. It normally is
not included in reports of lipid measures in the clinical
setting. We propose that it should be routinely calculated,
and this would best be done as an automatic print out. Theidentification of a high ratio can alert a clinician or health
care provider to potential risk. Its presence can point the
way to further investigations that may prove informative. At
least half of patients with a high ratio will have a low CRF
and deserve greater attention to physical activity habits.
Many of the concomitants to have high TG/HDL-C ratio can
be corrected through efficient lifestyle intervention.
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Supplemental Table 1 Balke protocol thresholds of treadmill time for fitness categories across age strata in men developed in the
Cooper Center Longitudinal Study
Age group
Cardiorespiratory fitness categories
Category 1 Category 2 Category 3 Category 4 Category 5
Treadmill time (min)
20–39 years #15.00 15.02–18.00 18.02–20.33 20.35–23.58 $23.60
40–49 years #13.50 13.52–16.05 16.07–19.00 19.02–22.02 $22.03
50–59 years #11.00 11.02–13.58 13.60–16.00 16.02–19.17 $19.18
$60 #7.75 7.77–10.50 10.52–13.07 13.08–16.35 $16.37
Cardiorespiratory fitness categories used in the present study are based on treadmill time (min) duration for each age decade in men participating in
the Cooper Clinic Longitudinal Study.20
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